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Introduction 
MicroRNAs (miRNAs) are small (~22 nt) evolutionarily-conserved single stranded RNA species 
that function as potent negative regulators of gene expression (Ambros 2004; Bartel 2004; Lim et 
al. 2005). miRNAs repress gene expression via their ability to hybridize with the 3’ UTR of 
target mRNAs, and, in turn, trigger mRNA degradation and/or translational repression (reviewed 
in (Bartel 2009; Eulalio et al. 2008; Carthew and Sontheimer 2009)). miRNA expression is often 
cell-type and tissue-specific (Lagos-Quintana et al. 2002; Kim et al. 2004b; Kosik 2006; Cao et 
al. 2006), and within the central nervous system (CNS), recent work has indicated that they play 
key roles in a wide range of physiological processes. Along these lines, during development, the 
disruption of miRNA expression through genetic deletion of Dicer results in aberrant neuronal 
development and differentiation, as well as altered morphogenesis and neuronal signaling 
(Cuellar et al. 2008; Giraldez et al. 2005). Furthermore, recent work reveals specific roles for 
miRNAs (including miR-124a, miR-134 and miR-375) in dendritogenesis and axonal path 
finding (Schratt et al. 2006; Abdelmohsen et al. 2010; Fiore et al. 2009; Sanuki et al. 2011). 
 As more neuronal-enriched miRNA have been identified, the possibility of a prominent 
role for miRNA in the regulation of neuronal activity and cognition has emerged (Konopka et al. 
2011; Im et al. 2010).  Among these is the CREB-regulated miRNA132 (miR-132) (Cheng et al. 2007; 
Remenyi et al. 2010; Wibrand et al. 2010; Nudelman et al. 2010). miR-132 is transcribed from the intron 
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of a non-coding RNA and has been shown to alter both neuronal morphology and synaptic physiology 
(Hansen et al. 2010b; Vo et al. 2005). Along these lines, the effects of miR-132 on dendritic 
morphogenesis appears, in part, to be mediated by its suppression of p250GAP, thus leading to a de-
repression of Rac1-PAK-mediatetd spinogenesis (Impey et al. 2010; Wayman et al. 2008). Furthermore, 
selective deletion of the miR-132/212 locus led to significant alterations in neuronal morphology in new-
born adult hippocampal neurons, including decreased dendritic complexity and spine density (Magill et 
al. 2010).  
Given its complex, and context-specific effects on neuronal structure and function, an 
examination of the potential role of miR-132 as a regulator of cognition is highly merited. In line 
with this, we recently reported that robust transgenic over-expression of miR-132 in the forebrain 
increased spine density and caused deficits in novel object recognition memory (Hansen et al. 
2010b). Interestingly, in this study, transgenic miR-132 expression levels were quite high (> 5-
fold over basal expression), approximating the expression level of endogenous miR-132 
following seizure activity (Jimenez-Mateos et al. 2011). This high level of transgenic miR-132 
raised the possibility that our reported effects on novel object recognition memory may not serve 
as a useful guide to understand the role of miR-132 under normal physiological conditions such 
as following learning/memory tasks. We hypothesized that under normal physiological 
conditions, miR-132 could couple neuronal activity to enhanced cognition.  
To begin to address this question, we employed a combination of in vivo detection 
methods and transgenic mouse models to assess the functional effects of miR-132 on 
hippocampal dependent learning and memory. Here we show that endogenous miR-132 is 
induced in response to a spatial memory task, and that this ‘induced’ level of miR-132 enhances 
cognition. Moreover, over-expression (> 3-fold) of miR-132 leads to profound cognitive deficits. 
Together, these data indicate that miR-132 is part of a normal cellular signaling pathway that 
couples associative learning paradigms to memory formation, and that dysregulation of its 
expression leads to impaired cognition.  
 
Methods and Materials 
Ethics Statement 
All animal breeding and experimental procedures were approved by the Ohio State University 
Animal Care and Use Committee (protocol number: 2008A0227).  
 
tTA::miR132 mice 
Generation of the tetracycline-regulated bidirectional miR-132/cyan fluorescent protein 
transgenic mouse line (here referred to as: miR-132 transgenic mice) was recently described 
(Hansen et al. 2010b). To drive transgene expression, the TRE-miR-132 transgenic mice were 
crossed with the CaMKII tTA driver line (Mayford et al. 1996), which allowed for robust 
transgene expression within excitatory forebrain neurons (Hansen et al. 2010b). Temporal 
regulation of tTA (i.e., ‘Tet-off’) inducible miR-132 transgene expression was accomplished by 
administration of doxycycline (0.40-200 µg/mL) to the drinking water. Doxycycline was also 
administered to monotransgenic controls, and was shown to have no cellular level or behavioral 
effect relative to untreated animals (data not shown).  
For the examination of neuronal spine density, tTA::miR132 mice were crossed with a 
transgenic line expressing green fluorescent protein (GFP) in a subpopulation of hippocampal 
neurons under the control of the thy1 promoter (Morris 1985). Thy-1 GFP mice (Feng et al. 
2000) were generously provided by Gouping Feng (Duke University). Of note, the Thy-1-driven 
morphological marker does not affect the electrophysiological or the morphological properties 
(i.e., dendrite length and number, spine number and density, soma size) of hippocampal neurons 
(Vuksic et al. 2008).  
 
RT-PCR miRNA quantitation 
The NCode™ VILO™miRNA cDNA Synthesis Kit (Invitrogen) was used to create a cDNA 
library of total hippocampal RNA that was extracted by TRIzol isolation (Invitrogen) from 
nontransgenic and tTA::miR132 animals. miRNAs were polyadenylated with 
Poly(A)polymerase and reverse transcribed with universally-tagged 5’ oligo-dT primer 
(Invitrogen). cDNA amplification was performed using SYBR green reporter-based qPCR 
(Applied Biosystems) and the miScript Primers (Qiagen). Data were normalized to RNU6B_2 
cDNA levels. 
 
Tissue Processing and Fluorescent in situ hybridization 
All tissue preparation was carried out under RNAse-free conditions and with use of DEPC-
treated solutions. Brain tissue was removed after cervical dislocation and post-fixed in 4% 
paraformaldehyde for 4 h at 4°C and cryoprotected with 30% sucrose in PBS. Hippocampus-
containing sections were then thin-cut (40 µm) on a freezing microtome. Sections were 
incubated (5 min) with the nuclear stain DRAQ5 (1:10,000; BioStatus Limited, UK) and washed 
3x in PBS. 
Fluorescent in situ hybridization (FISH) against miRNA was carried out according to 
procedures outlined by Nuovo (2010) (Nuovo 2010). In brief, tissue was mounted onto slides, 
followed by a short digestion with pepsin. Tissue was then hybridized overnight with 
fluorescein-conjugated locked nucleic acid (LNA) probes (Obernosterer et al. 2007) to mouse 
miR-132, snRNA U6, or an Exiqon-designed ‘scramble’ negative control probe (Exiqon). The 
signal from the fluorescein-conjugated probes was amplified with an anti-fluorescein Alexa 488 
signal detection kit (Invitrogen).  
Analysis of FISH intensity was examined using the above equipment and software to 
acquire images at 40x. Images of the relevant cellular layers of FISH-labeled sections were 
traced digitally and intensity levels were analyzed with MetaMorph software (Molecular 
Devices). Intensity levels were normalized by background subtraction and presented relative to 
staining in naïve animals.  
 
Immunofluorescent Labeling 
Tissue was fixed and prepared as described above. Sections were then washed and 
permeabilized in PBS with 1% Triton X-100 PBST (3x, 10 min each). Sections were blocked for 
1 h in10% normal goat serum in PBS. Sections were incubated overnight at 4°C in rabbit 
polyclonal anti-GFP antibody (acquired from Dr. Luc G. Berthiaume, University of Alberta, 
Canada). The GFP antibody was used at 1:2,500 to detect the TRE-regulated CFP transgene, and 
1:20,000 to detect the Thy-1-regulated GFP transgene. Of note, the expression of the tet-
responsive CFP transgene is markedly lower than the Thy-1 driven GFP, and thus, by using this 
relatively low concentration of the primary antibody, we are able to distinguish the Thy-1 GFP 
transgene from the CFP transgene. A series of control data sets which confirm successful 
discrimination of the two signals is presented in (Hansen et al. 2010b).  
Sections were then incubated in Alexa Fluor-488-conjugated goat anti-mouse IgG 
antibody (1:1000; Invitrogen, Carlsbad, CA) for three hours at room temperature. Tissue was 
washed in PBST for a total of 30 min between each labeling step. Sections were mounted on 
slides with Fluoromount-G (SouthernBiotech, Birmingham, Alabama, AL).  For clarity, CFP 
transgene immunolabeling (Fig. 3b) is presented as a blue/cyan fluorescent signal.   
 
Thy-1 GFP Morphometric Analysis  
CA1 basal dendrites (ten per animal) were examined for morphological changes in 40 µm-thick 
coronal sections. Images of Thy-1 GFP immunofluorescence of 20 µm dendritic segments 
extending 90-120 µm from the cell soma were captured using confocal microscopy. Processes 
extending > 0.5 µm from the dendrite were counted as dendritic spines and included both 
mushroom-shaped and filopodia-like protrusions. Images were acquired at 63x with 4.3x optical 
zoom, using a Zeiss 510 confocal microscope and LSM Software Zen. 
 
Behavioral Analysis 
Mature (6-8 weeks), age and gender-matched animals were used for all behavioral paradigms. 
Novel object recognition was adapted from procedure described by Bevins and Besheer (Bevins 
and Besheer 2006). Briefly, each animal was allowed a 10 min training session with exposure to 
two identical, non-toxic objects (glass or hard plastic items). After training, animals were 
returned to the home cage for a 30-min delay period. After the retention interval, each animal 
was returned to the testing arena in which one familiar object was replaced with a novel object. 
Animals were given 5 min to explore while being video recorded for later scoring. Subsequently, 
exploration time for each object was timed, as identified as the animal’s nose being within 2 cm 
of, and pointed toward, the object. The discrimination ratio was calculated as [‘exploration time 
with novel object’ / (‘time with novel object’ + ‘time with familiar object’)]. Of note, all animals 
demonstrated similar ambulatory capacity, as demonstrated by motility of exploration. All 
groups exhibited similar total exploration time of their environment.  
 Barnes maze testing followed procedures outlined by Sunyer et al (Sunyer et al. 2007; 
Barnes 1979). In summary, a circular and elevated maze platform (92 cm diameter, 76 cm above 
the floor) with 20 equally-spaced holes was positioned in a brightly lit room. An escape box was 
placed under one of the holes and visual cues (geometric shapes) were placed on the walls that 
surround the maze. Bright light (120W in addition to overhead lighting) and an electronic 
metronome (Boss DB-66, 440 Hz, 65 dB) were used as aversive stimuli. Mice were given five 
days of training, during which mice experienced three 5-minute trials of free exploration with a 
10-min inter-trial interval. A trial ended once the mouse entered the escape box, or after 5 
minutes of exploration had elapsed (at which point it was gently guided to the target box). Nose 
pokes into incorrect holes and latency to reach target hole were recorded as measures of maze 
performance over all trials. To distinguish the potentially-subtle phenotypic effects of graded 
transgene expression, Barnes maze testing on animals with titered doxycycline administration 
(Fig. 3) was conducted under slightly less aversive conditions, relative to those used to test the 
gross effects of robust transgenic miR-132 (Fig. 4) to avoid any ceiling effect related to 
minimum training errors and latency to escape. 
Successful acquisition of the Barnes maze task was demonstrated by a probe trial that 
occurred 24 hours after the final acquisition day. Probe trial consisted of a single 90-second 
exploration of the maze with the escape box removed. All animals demonstrated a capacity to 
locate the target hole, and no significant differences were found between groups on the probe day 
(data not shown). 
Examination of learning-induced miR-132 expression in wild-type animals was 
conducted using a modified Barnes maze paradigm in order to capture changes in early miRNA 
expression. Animals were given two days of Barnes maze training, by which point spatial 
memory appeared to be largely established, as demonstrated by improved performance across 
measures of both latency and errors (Fig. 3e). Control animals were also handled and exposed to 
aversive stimuli, but were not trained to escape to the target box. Tissue was isolated for in situ 
hybridization twelve hours after the last trial on day two, reflecting both the time course of 
miRNA processing (Schmittgen et al. 2008), as well as similar paradigms used to detect early 
signaling mechanisms of memory formation (Vázquez et al. 2000; Kim et al. 2004a).   
Statistics 
All values presented here are given as means ± SEM. Unless otherwise noted, a value of p < 0.05 
was accepted as statistically significant. Comparisons between two groups were made by 
Student’s t-test. Significance for qPCR, spine density, and within-day Barnes maze analysis 
conducted by SPSS 19.0 and were assessed using one-way ANOVA analysis, followed by 
Fisher's least significant difference (LSD) test. Repeated Measures Mixed-Model ANOVA was 
used for multi-day Barnes maze training comparison.  
 
Results 
Expression of miR-132 in the hippocampus 
To begin our analysis, we profiled miR-132 expression in the mature hippocampus using 
fluorescent in situ hybridization (FISH). To this end, coronal sections from adult wild-type mice 
animals were incubated with a fluorescein-conjugated locked nucleic acid (LNA) probe against 
the mature form of miR-132 and labeled with the DNA/nuclear marker DRAQ5 (Fig. 1). 
Representative data reveal marked expression of miR-132 in all excitatory sublayers of the 
hippocampus (i.e., CA1, CA2, CA3, and GCL), as well as in the cortex (Fig. 1a, b). Higher 
magnification imaging of tissue labeling confirmed that miR-132 expression was largely 
restricted to neuronal cell populations (Fig. 2). Hence, in contrast to the robust expression 
detected in the CA1 and GCL sublayers, minimal labeling was detected within cells (largely non-
neuronal) located in the molecular layer of the dentate gyrus (Fig. 2A-C). A control set of 
experiments in which tissue was labeled with a ‘scrambled’ fluorescein-conjugated LNA probe 
that does not detect known microRNA species revealed little labeling (Fig. 1 C). As a positive 
control, tissue was labeled with an LNA-probe against the ubiquitously expressed snRNA U6. 
As expected, U6 labeling was detected throughout the hippocampus. Together these indicate 
neuronal enrichment of miR-132 in the adult hippocampus.  
 
Induction of miR-132 after spatial learning 
A number of studies have shown that miR-132 expression is tightly regulated by CREB 
(Jimenez-Mateos et al. 2011; Cheng et al. 2007). Given that CREB plays a central role in 
transcriptionally-dependent forms of learning and memory, it was reasonable to posit that miR-
132 may be inducibly expressed during memory formation. To begin to test this idea, we profiled 
hippocampal miR-132 expression in wild-type animals undergoing Barnes maze spatial memory 
training (described in detail below). Because the greatest period of memory formation appears to 
occur during the first two days of training (as demonstrated by both reduced latency and errors, 
and successful escape to the target box: Fig. 3d), animals were given two days of training (thee 
trials per day). Tissue was then collected twelve hours later, and miR-132 expression was 
measured via FISH (Fig. 2). Quantitative analysis of the FISH signal revealed that miR-132 
expression was significantly higher (~1.5 fold) in the CA1, CA3, and GCL cell layers of Barnes 
maze-trained animals, relative to control animals that were naïve to the learning paradigm (Fig. 
2a, b and d). In naïve mice, miR-132 expression in the CA1 layer was heterogeneous, with 
limited expression in some cells, while other cells expressed relatively high levels. Interestingly, 
training resulted in an elevated and more uniform miR-132 signal across the CA1 sublayer (Fig. 
2a). Of note, learning did not increase miR-132 expression in non-neuronal cells, including those 
occupying the molecular layer of the dentate gyrus (Fig. 2c and d). Together, these data show 
that miR-132 expression is significantly increased in response to the learning challenge. 
 
Cognitive enhancement in animals with moderate increases in transgenic miR-132 
Our previous work using a transgenic miR-132 mouse model revealed that robust over-
expression (>  3-fold, relative to endogenous levels) of miR-132 impaired learning and memory 
(Hansen et al. 2010b). Given our work here showing a relatively low-level of miR-132 induction 
following a learning paradigm, coupled with a number of studies showing that miR-132 affects 
neuronal plasticity (Impey et al. 2010; Wayman et al. 2008), we hypothesized that robust 
transgenic over-expression approach may not be a useful model to dissect the contribution of 
endogenous miRNA-132 to cognition. Hence, in an attempt to provide a more telling model, we 
returned to our miR-132 transgenic mouse, and tested the effects of low-level transgene 
expression on Barnes maze learning. As outlined in our previous paper (Hansen et al. 2010b), to 
drive transgene expression in forebrain excitatory neurons, the tetracycline-regulated miR-
132/CFP bidirectional transgenic mouse line was crossed with a αCaMKII tTA driver line 
(Mayford et al. 1996) (denoted as ‘tTA::miR132’ mice). To negatively regulate transgenic miR-
132 expression, varying concentrations of doxycycline were added to the drinking water, and 
miR-132 expression was profiled two weeks later. As expected, increasing the concentration of 
doxycycline in the drinking water (0.4 µg/mL-50 µg/mL) resulted in an incremental repression 
of transgene expression in the hippocampus, as measured by qPCR (Fig. 3a). Consistent with 
this, administration of 200 µg/mL of doxycycline led to a suppression of CFP expression (Fig. 
3b). To approximate the wild-type expression level of miR-132 after 2-days of Barnes maze 
learning, we chose an intermediate doxycycline concentration (0.4 µg/mL) that yielded an ~ 2-
fold increase in transgene expression over control tTA mice (Fig. 3a). For the behavioral assay, 
tTA::miR132 animals were treated with this dose of doxycycline for three weeks and then tested 
on the Barnes maze paradigm. Animals were given five consecutive days of training (three trials 
per day), during which they were allowed to explore the circular Barnes maze platform 
(maximum of five minutes per trial). Bright lights and metronomic clicks provided aversive 
stimuli sufficient to motivate escape to a target hole fitted with an escape box. Learning 
performance was measured by latency to escape, as well as errors made before escaping (nose 
pokes to incorrect holes). Remarkably, doxycycline-treated tTA::miR132 animals showed 
excellent Barnes maze performance, exhibiting both reduced latencies and fewer errors relative 
to monotransgenic (tTA) littermates that also received doxycycline (Fig. 3c and d). Hence, 
moderate increases in transgenic miR-132 significantly enhanced cognitive capacity, suggesting 
that the learning-evoked increase in endogenous miR-132 also enhances cognition. 
 
Cognitive impairment in mice over-expressing miR-132 
As noted, our previous work demonstrated that robust transgenic over-expression of miR-132 
(i.e., no doxycycline treatment) impaired novel object recognition memory (Hansen et al. 
2010b). Here, we furthered this line of inquiry by testing the effects of transgenic miR-132 over-
expression on spatial memory capacity, and by testing the plastic nature of the learning 
phenotype. 
In the Barnes maze assay, mice that expressed high levels of transgenic miR-132 (no 
doxycycline) showed significant impairment in spatial memory capacity, as demonstrated by 
poor performance in maze acquisition. While all groups improved across the five days of 
acquisition, the transgenic group without doxycycline exhibited both a longer latency to escape 
to the target hole, as well as an increase in errors made before escape, as compared to 
monotransgenic littermates (Fig. 4a and b). These data are consistent with our prior work using 
the novel object recognition test, and thus provide further support for the idea that miR-132 
shapes cognitive capacity.  
To examine whether the cognitive deficits observed in tTA::miR132 were reversible, a 
separate group of miR-132:tTA animals received doxycycline through the drinking water at a 
dose sufficient to fully suppress transgene expression (200 µg/mL). After three weeks of 
treatment, these animals exhibited Barnes maze performance that was indistinguishable from 
tTA monotransgenic mice (Fig. 4a and b). Similarly, the poor performance of transgenic miR-
132:tTA animals assayed via the novel object recognition test  (Hansen et al. 2010b), was 
reversed by maintaining animals on doxycycline treatment for three weeks (Fig. 4c). For this 
assay, animals were given 10 minutes to explore two identical objects placed on opposite sides of 
a testing arena. After removal for a 30-minute delay, animals were returned to the arena, in 
which one familiar object had been replaced by a novel one. Animals were allowed five minutes 
of investigation, during which exploration time with each object was recorded. In the absence of 
doxycycline, tTA::miR132 mice spent equal time with both the novel and familiar objects. 
However, a separate cohort of animals that had been treated with doxycycline (200 µg/mL) for 
three weeks spent significantly more time with the novel object, paralleling the behavior of tTA 
monotransgenic mice. Thus, these data indicate that cognitive capacity is tightly and dynamically 
linked to the expression level of miR-132. 
 
Reversibility of increased spine density in tTA::miR132 animals 
Our previous work demonstrated that, in the absence of doxycycline treatment, tTA::miR132 
mice exhibit a marked increase in dendritic spine density relative to monotransgenic mice 
(Hansen et al. 2010b). Again, although increased spine density is often associated with enhanced 
cognitive capacity, excessive spine formation has been linked to cognitive deficits (Hutsler and 
Zhang 2010). Here, we examined spine density in mature tTA::miR132 animals after receiving 
three weeks of doxycycline treatment (200 µg/mL). For these experiments, the miR-132 
transgenic mice were crossed with a Thy-1 GFP mouse line that has been used extensively to 
examine neuronal morphology and plasticity (Vuksic et al. 2008; Feng et al. 2000; Hansen et al. 
2010b). Morphometric analysis revealed that spine density in CA1 basal dendrites of 
TA::miR132 mice treated with doxycycline was indistinguishable from tTA monotransgenic 
mice (Fig. 5). Further, consistent with our prior work, spine density was significantly enhanced 
in tTA::miR132 mice that were not treated with doxycycline. This ostensible doxycycline-
mediated reversibility of the miR-132 spine density phenotype parallels the reversibly of the 
miR-132 cognitive phenotype, and thus suggests that miR-132 is a dynamic and transient 
regulator of neuronal plasticity. Together, these data, along with the noted work on miR-132 
targets, indicate a key role for this non-coding RNA in activity-inducible CNS physiology and 
function.  
 
Discussion 
The central goal of this project was to further our understanding of the role of miR-132 in 
hippocampal-dependent learning and memory formation. To this end, we demonstrated that 
endogenous miR-132 is expressed in excitatory cell layers throughout the hippocampus, and that 
miR-132 is induced in response to a spatial learning task. Using these data as a guide, we 
employed a tetracycline-regulated operon to drive the expression of transgenic miR-132 and 
assess its effects on cognition. These data reveal that cognitive capacity is tightly regulated by 
miR-132. Hence, physiological levels of miR-132 enhance cognition, whereas supra-
physiological levels of the miRNA lead to cognitive deficits. Together, these data indicate that 
miR-132 plays a key role in shaping cognitive capacity.  
Next, we turned to the question of miR-132 inducible expression following the 
presentation of a spatial learning task. For this assay, we used the Barnes maze paradigm, and 
profiled miR-132 expression after two days of training. One key motivation for choosing a 
relatively short time point following initiation of the learning paradigm was the desire to capture 
ostensible early-stage gene expression, which would be expected to play a central role in the 
induction of learning. At this time point, significant upregulation of miR-132 was detected in the 
excitatory cell layers of the hippocampus, suggesting that miR-132 induction occurs during a 
period of memory consolidation. Interestingly, these data are consistent with recent PCR-based 
profiling data which showed that contextual fear conditioning triggers a rapid increase in the 
expression of the primary transcript of miR-132 (Nudelman et al. 2010), although a learning-
evoked increase in the mature form of miR-132 was not detected in the noted study. Together, 
these data suggest that miR-132 is part of the CREB-regulated, learning evoked transcriptional 
response, and, given the time course of induction, raises the prospect that miR-132 plays a role in 
CREB-dependent memory consolidation.  
In our prior report, we found that transgenic miR-132 expression led to an increase in 
overall dendritic spine density in the hippocampus, and a deficit in novel object recognition 
memory (Hansen et al. 2010b). Here, the examination of transgenic miR-132’s action on learning 
and memory was extended to the Barnes maze, where we found that over-expression of miR-132 
(no doxycycline treatment) led to a profound deficit in spatial learning capacity. On its face, 
pairing our current data showing that learning induces an increase in miR-132 expression with 
the our prior data showing that transgenic over-expression of miR-132 triggers cognitive deficits 
would suggest that endogenous miR-132 functions as a negative regulator of learning and 
memory. However, a more circumspect examination of the data raises issues with this 
interpretation. Central to this concern is the marked difference between the miR-132 induction 
level evoked by learning and the level driven by the tet-operon. Notably, wild-type animals 
showed learning-evoked increase in expression of ~1.5-fold, whereas in transgenic mice, miR-
132 expression was elevated > 3-fold over control levels (in the absence of doxycycline). This 
transgenic, supra-physiological, level of miR-132 could profoundly dysregulate neuronal 
physiology and, in turn, cognition. To address this possibility, we employed the doxycycline 
regulatory system to modulate transgenic miR-132 levels, and assess the effects of moderate 
miR-132 induction that approximates the learning-evoked expression level. Under these 
conditions, tTA::miR132 animals showed significantly enhanced spatial memory capacity 
relative to nontransgenic littermates. These expression-level-specific effects of miR-132 led us to 
envision miRNA functionality as an inverted U-shaped curve, where low or supra-physiological 
levels of the miRNA result in cognitive impairment, and where miR-132 enhances cognitive 
capacity only within a fairly limited expression range (Fig. 6). Our data raise the prospect that a 
limited range of miR-132 expression leads to morphological plasticity conducive to normal 
cognitive capacity, and that relatively high levels disrupt cognition via aberrant 
spinogenesis/synaptic connection. Consistent with this idea, our data reveal that doxycycline 
suppression of transgenic miR-132 reversed both the cognitive deficits and the spinogenesis 
phenotype.  
Given the complexity of miRNA expression and the plethora of miR-132 targets that 
have yet to be validated, newly developed approaches, including array and deep sequencing 
assays designed to quantify gene expression levels and identify gene networks, may be required 
to begin to unravel the mechanisms by which miR-132 sculpts cognition.  
 
  
Figures 
 
 
Fig. 1 miR-132 expression in the hippocampus (A) Fluorescent in situ hybridization (FISH) 
using an LNA-antisense probe directed against miR-132 reveals robust miR-132 expression 
throughout the cortex and hippocampus of wild-type animals. (B) Within the hippocampus, 
marked excitatory-layer-specific expression of miR-132 was confirmed by merging the miR-132 
fluorescence micrograph in A with a fluorescence micrograph image of DRAQ5 labeling (red). 
(C) Representative FISH labeling using a scrambled miRNA probe: minimal labeling was 
detected. (D) As a positive control for the FISH labeling approach, hippocampal sections were 
incubated with an antisense probe against the snRNA U6. CA1-3, hippocampal subfields; GCL, 
granule cell layer. Scale bar: 400 µm.  
 
 Fig. 2 miR-132 expression is induced in response to the Barnes maze learning paradigm 
Hippocampal miR-132 expression was examined by FISH in control animals, and in animals that 
experienced two days of Barnes maze learning. (A-C) In animals expo sed to the learning 
paradigm, expression of miR-132 (green) was increased in the CA1 (A), CA3 (not shown), and 
GCL (B) excitatory cell layers relative to control animals, but not in the molecular layer (ML: 
C). Tissue was also labeled with the DNA stain DRAQ5 (red). Scale bar: 100 µm. (D) 
Quantification of relative fluorescent intensity ± SEM in CA1, CA3, GCL and ML; NS, not 
significant. *p<0.05, **p<0.01, two-tailed t-test, n=6 animals for each group.  
 
 Fig. 3 Limited expression of transgenic miR-132 enhances Barnes maze performance (A) 
tTA::miR132 animals exhibited robust expression of miR-132 in the hippocampus by qPCR in 
the absences of doxycycline, while the addition of doxycycline administration to the drinking 
water for two weeks led to a dose-dependent reduction in miR-132 expression. From 2-10 µg/mL 
of doxycycline, miR-132 levels in tTA::miR132 mice were not significantly different from levels 
in monotransgenic animals (tTA). Total hippocampal RNA was isolated, reverse-transcribed, and 
miR-132 cDNA was profiled via real-time PCR. Mature miR-132  expression was normalized to 
RNU6B_2 cDNA levels and then presented as mean ± SEM (n=3 per group) expression relative 
to the tTA (No dox) condition, which was set equal to a value of 1.  (B) Immunofluorescent 
analysis of cyan fluorescent protein (CFP) expression in tTA::miR132 mice confirms robust 
transgene expression in the absence of doxycycline administration, and potent suppression of 
transgene expression following two weeks of doxycycline administration (200 µg/mL). Scale 
bars: 200 µm. (C,D) Animals (tTA and tTA::miR132) were administered doxycycline (0.4 
µg/mL) for three weeks prior to Barnes maze testing. Under this condition, tTA::miR132 animals 
exhibited faster escape latency (C) and fewer training errors (D) than monotransgenic littermates. 
All groups improved significantly across five days of acquisition: Repeated Measures Mixed-
Model ANOVA, F(4,80)=6.685, P<.001 (Latency), F(4,80)=17.723, P<.001 (Training Errors). 
Differences within day: one-way ANOVA, *p<0.05. n=11 animals per group.  
 
Figure 4. tTA::miR132 animals under conditions 
of robust transgenic miR-132 show cognitive 
impairment. (A,B) In the absence of doxycycline 
treatment, tTA::miR132 animals undergoing Barnes 
maze testing showed increased latency to escape (A), 
as well as increased training errors (B) relative to 
monotransgenic littermates (tTA). In a separate 
group of tTA::miR132 mice, doxycycline treatment 
(200 mg/mL: three weeks) suppressed the cognitive 
impairment observed in the tTA::miR132 animals 
that were not treated with doxycycline. tTA animals 
were also treated with doxycycline, but showed no 
differences from untreated controls (data not shown). 
All experimental groups improved significantly 
across five days of acquisition: Repeated Measures 
Mixed-Model ANOVA F(4,160)=33.429, P<.001 
(Latency), F(4,156)=45.65, P<.001 (Training Errors). 
Differences within day: one-way ANOVA, *p<0.05, **p<0.01. n=12 animals per group. (C) In 
the absence of doxycycline, tTA::miR132 animals showed significant impairment in novel object 
recognition memory. Hence, tTA::miR132 mice did not exhibit greater exploratory bias towards 
the novel versus the familiar object. In contrast, blocking transgenic miR-132 expression via 
doxycycline administration (200 µg/mL: three weeks) suppressed the novel object recognition 
impairment of tTA::miR132 animals. Hence, doxycycline-treated tTA::miR132 mice exhibited 
significantly greater exploration time with the novel object than with the familiar one, paralleling 
the behavioral phenotype of monotransgenic littermates (tTA). Data are presented as mean 
discrimination ratio ± SEM, *p<0.05, two-tailed t-test, n=5 animals per group. NS, not 
significant. 
 
Fig. 5 Transgenic miR-132-induced increases in 
spine density are suppressed by administration 
of doxycycline A Thy-1 driven GFP transgenic 
marker was used to examine spine density in 
tTA::miR132 mice. (A) Confocal images reveal an 
increase in spine density under conditions of robust 
miR-132 expression [tTA::miR132 (no 
doxycycline)] that is absent upon suppression of 
the transgene with doxycycline [tTA::miR132 (200 
µg/mL dox)]. Scale bar: 10 µm. (B) Graphical 
representation of the mean ± SEM spine density. 
One-way ANOVA, **P < 0.01, F(2,10)= 83.563, n=5 animals for each group.  
  
Fig. 6 Model depicting the proposed relationships between miR-132, neuronal morphology 
and cognition In this model, we propose that there is an optimal, and rather narrow, range of 
miR-132 expression which enhances cognitive capacity. Supra-physiological expression of miR-
132 leads to excessive spine density and cognitive deficits that compromise learning and 
memory formation. Further, limited basal and/or damped inducible expression of miR-132 is 
hypothesized to inhibit cognition, possibly via a paucity of spine formation. Hence, deviation 
from this optimized miR-132 expression level (either excessive induction or too little expression) 
may lead to the severe learning deficits that are characteristic of a variety of neurocognitive 
disorders.  
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